Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
- PMID: 33398198
- PMCID: PMC8148035
- DOI: 10.1038/s41588-020-00748-0
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Erratum in
-
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet. 2021 Mar;53(3):413. doi: 10.1038/s41588-021-00786-2. Nat Genet. 2021. PMID: 33473200 No abstract available.
Abstract
Prostate cancer is a highly heritable disease with large disparities in incidence rates across ancestry populations. We conducted a multiancestry meta-analysis of prostate cancer genome-wide association studies (107,247 cases and 127,006 controls) and identified 86 new genetic risk variants independently associated with prostate cancer risk, bringing the total to 269 known risk variants. The top genetic risk score (GRS) decile was associated with odds ratios that ranged from 5.06 (95% confidence interval (CI), 4.84-5.29) for men of European ancestry to 3.74 (95% CI, 3.36-4.17) for men of African ancestry. Men of African ancestry were estimated to have a mean GRS that was 2.18-times higher (95% CI, 2.14-2.22), and men of East Asian ancestry 0.73-times lower (95% CI, 0.71-0.76), than men of European ancestry. These findings support the role of germline variation contributing to population differences in prostate cancer risk, with the GRS offering an approach for personalized risk prediction.
Figures













References
-
- Groups., U.S.C.S.W. U.S. Cancer Statistics Data Visualizations Tool, based November 2018 submission data (1999–2016). U.S. Department of Health and Human Services, Centers for Disease Control and Preventions and National Cancer Institute; www.cdc.gov/cancer/dataviz, (June 2019).
-
- Amundadottir LT et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 38, 652–8 (2006). - PubMed
Methods-only References
Publication types
MeSH terms
Grants and funding
- 29017/CRUK_/Cancer Research UK/United Kingdom
- 17528/CRUK_/Cancer Research UK/United Kingdom
- U01 CA194393/CA/NCI NIH HHS/United States
- MC_QA137853/MRC_/Medical Research Council/United Kingdom
- UG1 CA189974/CA/NCI NIH HHS/United States
- U01 CA261339/CA/NCI NIH HHS/United States
- U19 CA148537/CA/NCI NIH HHS/United States
- U01 CA113913/CA/NCI NIH HHS/United States
- R00 CA246063/CA/NCI NIH HHS/United States
- P01 CA196569/CA/NCI NIH HHS/United States
- 203477/Z/16/Z/WT_/Wellcome Trust/United Kingdom
- P30 ES010126/ES/NIEHS NIH HHS/United States
- U10 CA037429/CA/NCI NIH HHS/United States
- U01 CA182883/CA/NCI NIH HHS/United States
- MC_PC_17228/MRC_/Medical Research Council/United Kingdom
- R01 CA194393/CA/NCI NIH HHS/United States
- 29019/CRUK_/Cancer Research UK/United Kingdom
- K99 CA246063/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases